| 000 | 01490 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515100121.0 | ||
| 264 | 0 | _c20080108 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0171-2004 | ||
| 024 | 7 |
_a10.1007/978-3-540-73259-4_9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShepard, H M | |
| 245 | 0 | 0 |
_aHerceptin. _h[electronic resource] |
| 260 |
_bHandbook of experimental pharmacology _c2008 |
||
| 300 |
_a183-219 p. _bdigital |
||
| 500 | _aPublication Type: Historical Article; Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHistory, 20th Century |
| 650 | 0 | 4 | _aHistory, 21st Century |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xhistory |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xchemistry |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTrastuzumab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aJin, P | |
| 700 | 1 | _aSlamon, D J | |
| 700 | 1 | _aPirot, Z | |
| 700 | 1 | _aManeval, D C | |
| 773 | 0 |
_tHandbook of experimental pharmacology _gno. 181 _gp. 183-219 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-540-73259-4_9 _zAvailable from publisher's website |
| 999 |
_c17585610 _d17585610 |
||